Clinical Trial Update: Study to Evaluate the Efficacy and Safety of BCX7353 as an Oral Treatment for the Prevention of HAE Attacks in Japan [Phase 3]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 3 study evaluating BCX7353, an oral therapy, for preventing hereditary angioedema attacks, with res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Angioedema

Drugs mentioned

• BCX7353

Snippet

Sponsor: BioCryst Pharmaceuticals | Conditions: Hereditary Angioedema, HAE | Phase 3 | Status: COMPLETED | Results posted: 2021-03-04